Company Information
MiNK Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class invariant natural killer T (iNKT) cell therapies to transform the lives of patients with cancer.
Stock Information
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Data provided by Kaleidoscope.